Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Berkeley Lights, Inc. (BLI : NSDQ)
 
 • Company Description   
Berkeley Lights Inc. is a Digital Cell Biology company. It focuses on development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights Inc. is based in EMERYVILLE, Calif.

Number of Employees: 100

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.98 Daily Weekly Monthly
20 Day Moving Average: 1,199,309 shares
Shares Outstanding: 67.83 (millions)
Market Capitalization: $337.78 (millions)
Beta: 2.40
52 Week High: $51.28
52 Week Low: $3.66
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.86% 3.08%
12 Week -32.88% -24.57%
Year To Date -72.61% -66.54%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5858 HORTON STREET SUITE 320
-
EMERYVILLE,CA 94608
USA
ph: 510-858-2855
fax: -
ir@berkeleylights.com http://www.berkeleylights.com
 
 • General Corporate Information   
Officers
Eric Hobbs - Chief Executive Officer
Kurt Wood - Chief Financial Officer
John Chiminski - Director
Jessica Hopfield - Director
Siddhartha Kadia - Director

Peer Information
Berkeley Lights, Inc. (CORR.)
Berkeley Lights, Inc. (RSPI)
Berkeley Lights, Inc. (CGXP)
Berkeley Lights, Inc. (BGEN)
Berkeley Lights, Inc. (GTBP)
Berkeley Lights, Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 084310101
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 67.83
Most Recent Split Date: (:1)
Beta: 2.40
Market Capitalization: $337.78 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.30 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.14 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.75
Price/Cash Flow: -
Price / Sales: 3.88
EPS Growth
vs. Year Ago Period: -33.33%
vs. Previous Quarter: -23.08%
Sales Growth
vs. Year Ago Period: 8.47%
vs. Previous Quarter: -12.85%
ROE
03/31/22 - -36.42
12/31/21 - -31.78
09/30/21 - -28.16
ROA
03/31/22 - -27.03
12/31/21 - -24.17
09/30/21 - -22.05
Current Ratio
03/31/22 - 7.52
12/31/21 - 7.04
09/30/21 - 7.17
Quick Ratio
03/31/22 - 6.95
12/31/21 - 6.60
09/30/21 - 6.78
Operating Margin
03/31/22 - -89.36
12/31/21 - -84.00
09/30/21 - -78.76
Net Margin
03/31/22 - -89.36
12/31/21 - -84.00
09/30/21 - -78.76
Pre-Tax Margin
03/31/22 - -89.42
12/31/21 - -84.06
09/30/21 - -78.61
Book Value
03/31/22 - 2.85
12/31/21 - 3.09
09/30/21 - 3.26
Inventory Turnover
03/31/22 - 2.07
12/31/21 - 2.25
09/30/21 - 2.39
Debt-to-Equity
03/31/22 - 0.10
12/31/21 - 0.09
09/30/21 - 0.09
Debt-to-Capital
03/31/22 - 9.29
12/31/21 - 8.67
09/30/21 - 8.23
 

Powered by Zacks Investment Research ©